TP53 and neoplasm: The dual effects of p53 on MHC-II expression in tumor cells and IECs, and IL12 production in APCs reflect that p53 exerts its function in a highly context-dependent manner which leads to increased anti-cancer immune response towards cancer cells and reduced inflammation in the GI tract to limit radiation-induced GI toxicity, respectively.